Streetbeat News

Analyst Ratings

AVY

Loop Capital analyst Christopher Kapsch maintains a Buy rating on Avery Dennison (NYSE:AVY) and raises the price target from $90 to $108.

Portfolio Pulse from Benzinga Newsdesk

June 01, 2023 | 12:30 pm

CPRI

TD Cowen analyst Oliver Chen maintains a Market Perform rating on Capri Holdings (NYSE:CPRI) and lowers the price target from $55 to $40.

Portfolio Pulse from Benzinga Newsdesk

June 01, 2023 | 12:28 pm

CMG

Argus Research analyst John Staszak maintains a Buy rating on Chipotle Mexican Grill (NYSE:CMG) and raises the price target from $2200 to $2400.

Portfolio Pulse from Benzinga Newsdesk

June 01, 2023 | 12:27 pm

NTAP

Stifel analyst Matthew Sheerin maintains a Buy rating on NetApp (NASDAQ:NTAP) and raises the price target from $75 to $80.

Portfolio Pulse from Benzinga Newsdesk

June 01, 2023 | 12:23 pm

TSLA

GLJ Research analyst Gordon Johnson warns that Tesla's valuation could collapse as competition intensifies, comparing it to the fate of Blackberry. Johnson has a Sell rating on the stock and a $24.33 price target. He notes that Tesla's recent stock surge has come despite bad news and may be due to the Treasury's liquidity injection into equity markets.

Portfolio Pulse from Shanthi Rexaline

June 01, 2023 | 12:22 pm

IEF

MDT

MRK

WMB

CNBC's 'Halftime Report Final Trades' featured recommendations from financial experts, including iShares 7-10 Year Treasury Bond ETF (IEF), Medtronic (MDT), Merck (MRK), and Williams Companies (WMB). Medtronic recently issued weak guidance and announced the acquisition of EOFlow, while Merck announced positive data from a Phase 3 trial for advanced renal cell carcinoma treatment. Williams Companies posted better-than-expected Q1 results.

Portfolio Pulse from Priya Nigam

June 01, 2023 | 12:21 pm

PHR

JMP Securities analyst Joe Goodwin reiterated a Market Outperform rating on Phreesia (NYSE:PHR) and maintained a $39 price target.

Portfolio Pulse from Benzinga Newsdesk

June 01, 2023 | 12:18 pm

ASND

Cantor Fitzgerald analyst Li Watsek reiterated an Overweight rating on Ascendis Pharma (NASDAQ:ASND) and maintained a $152 price target.

Portfolio Pulse from Benzinga Newsdesk

June 01, 2023 | 12:17 pm

OKTA

JMP Securities analyst Trevor Walsh has reiterated a Market Outperform rating on Okta (NASDAQ:OKTA) and maintained a $110 price target.

Portfolio Pulse from Benzinga Newsdesk

June 01, 2023 | 12:17 pm

LNTH

JMP Securities analyst David Turkaly has reiterated a Market Outperform rating on Lantheus Holdings (NASDAQ:LNTH) and maintained a $130 price target.

Portfolio Pulse from Benzinga Newsdesk

June 01, 2023 | 12:16 pm